Anti-Human CD182/CXCR2 Antibody (SAA1360) from ProteoGenix; catalogue ARO-A22956; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for your biotech research needs.
This antibody specifically targets the CD182/CXCR2 protein, a member of the G-protein coupled receptor family that plays a crucial role in the immune response and inflammation. It is highly expressed on neutrophils, monocytes, and lymphocytes, making it an ideal target for studying immune cell migration and activation.
Our Anti-Human CD182/CXCR2 Antibody has been extensively validated for its specificity and sensitivity in various applications, including flow cytometry, immunohistochemistry, and Western blotting. It has been shown to effectively detect the CD182/CXCR2 protein in both human and mouse samples.
One of the main applications of this antibody is in studying inflammatory diseases and their underlying mechanisms. The overexpression of CD182/CXCR2 has been linked to various inflammatory conditions, such as rheumatoid arthritis, asthma, and inflammatory bowel disease. Our antibody can help researchers better understand the role of this protein in these diseases and potentially identify new therapeutic targets.
In addition, our Anti-Human CD182/CXCR2 Antibody can also be used in cancer research. CD182/CXCR2 has been found to be involved in tumor growth and metastasis, making it a promising target for cancer therapy. Our antibody can aid in the identification and characterization of CD182/CXCR2 in cancer cells, providing valuable insights into its role in tumor progression.
For experimental use, our antibody has been successfully used in a wide range of studies, including cell migration assays, cell signaling studies, and in vivo models. Its high specificity and sensitivity make it a reliable tool for accurate and reproducible results.
In summary, our Anti-Human CD182/CXCR2 Antibody is a top-performing product for researchers interested in studying the immune response, inflammation, and cancer. With its proven effectiveness and versatility in various applications, it is a valuable addition to any biotech lab. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22956. For research use only.
Target: C-X-C chemokine receptor type 2, CD182, CDw128b, CXC-R2, CXCR-2, CXCR2, GRO/MGSA receptor, High affinity interleukin-8 receptor B, IL-8 receptor type 2, IL-8R B, IL8RB; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: IF/ICC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
